1-231337272-C-CT
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP5_Moderate
The NM_175876.5(EXOC8):c.473dupA(p.Gln159AlafsTer9) variant causes a frameshift change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Consequence
NM_175876.5 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Neurodevelopmental disorder with microcephaly, seizures, and brain atrophy Pathogenic:1
Variant summary: EXOC8 c.473dupA (p.Gln159AlafsX9) results in a premature termination codon, predicted to cause a truncation of the encoded protein. The variant was absent in 245150 control chromosomes (gnomAD). To our knowledge, no occurrence of c.473dupA in individuals affected with neurodevelopmental disorder with microcephaly, seizures, and brain atrophy and no experimental evidence demonstrating its impact on protein function have been reported. Two downstream truncations (example: p.E572*, pAsp607*) have been reported in the literature in homozygous individuals affected with brain atrophy, seizures, developmental delay and microcephaly (PMID: 35460391, 32103185) where the variant segregated with the disease in two large families. No submitters have cited clinical-significance assessments for this variant to ClinVar. Based on the evidence outlined above, the variant was classified as likely pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.